Critical Perfusion Overview

  • Founded
  • 2008

Founded
  • Status
  • Out of Business

  • Employees
  • 4

Employees
  • Latest Deal Type
  • Out of Business

Critical Perfusion General Information

Description

Developer of a minimally-invasive system for monitoring tissue perfusion. The company helps in easing critical assessment of critically-ill patients in intensive care units

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Primary Office
  • 2225 East Bayshore Road
  • Suite 200
  • Palo Alto, CA 94303
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Critical Perfusion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Mar-2018 Completed Out of Business
1. Angel (individual) 16-Dec-2009 Completed Startup
To view Critical Perfusion’s complete valuation and funding history, request access »

Critical Perfusion Patents

Critical Perfusion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2408364-A1 Systems and method for characteristic parameter estimation of gastric impedance spectra in humans Inactive 16-Mar-2009 000000000
EP-2408364-A4 Systems and method for characteristic parameter estimation of gastric impedance spectra in humans Inactive 16-Mar-2009 000000000
JP-2012520739-A System and method for characteristic parameter evaluation of human stomach impedance spectrum Pending 16-Mar-2009 000000000
US-6970738-B1 Complex impedance spectrometer using parallel demodulation and digital conversion Active 04-Feb-2002 000000000 00
EP-1174080-B1 Catheter for use in a system for monitoring mucosal damage in hollow viscous organs Inactive 19-Jul-2000 A61B5/05
To view Critical Perfusion’s complete patent history, request access »

Critical Perfusion Executive Team (1)

Name Title Board Seat Contact Info
Jerry Gibson President & Chief Executive Officer
To view Critical Perfusion’s complete executive team members history, request access »

Critical Perfusion Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial